标题: Selection of Embryonic Stem Cell-Derived Enhanced Green Fluorescent Protein-Posi [打印本页] 作者: 江边孤钓 时间: 2009-3-5 00:55 标题: Selection of Embryonic Stem Cell-Derived Enhanced Green Fluorescent Protein-Posi
作者：Eva Hedlunda,b,c, Jan Pruszaka,c, Andrew Ferreea,c, Angel Viuelaa,c, Sunghoi Honga,c, Ole Isacsona,c, Kwang-Soo Kima,b作者单位：aUdall Parkinson 3 c5 Y X' W$ C: a7 z$ O5 w( p' F 6 i1 O% J# Y' w* f; X, e
0 f) ~6 W* `% `' }! t' } % d B+ k% j7 G/ p
" F6 C( L6 ^7 M5 w" g ! @7 N* A( ?! T5 ^4 y
, h! P/ e+ Y5 H- |+ g: t+ R 7 u: A! g% X, \0 d4 c6 S8 f t
! T6 `% m! [4 h7 w9 _+ P
5 _ r# w4 B$ i
- ~* ?3 d) D) H/ j
# x, t1 P6 f- Y) }4 a $ {4 f: r! E7 ?: l! P0 w
【摘要】 , L9 Y* O7 n+ ^7 [* `* }3 U Transplantation of mouse embryonic stem (mES) cells can restore function in Parkinson disease models, but can generate teratomas. Purification of dopamine neurons derived from embryonic stem cells by fluorescence-activated cell sorting (FACS) could provide a functional cell population for transplantation while eliminating the risk of teratoma formation. Here we used the tyrosine hydroxylase (TH) promoter to drive enhanced green fluorescent protein (eGFP) expression in mES cells. First, we evaluated 2.5-kilobase (kb) and 9-kb TH promoter fragments and showed that clones generated using the 9-kb fragment produced significantly more eGFP /TH neurons. We selected the 9-kb TH clone with the highest eGFP/TH overlap for further differentiation, FACS, and transplantation experiments. Grafts contained large numbers of eGFP dopamine neurons of an appropriate phenotype. However, there were also numerous eGFP cells that did not express TH and did not have a neuronal morphology. In addition, we found cells in the grafts representing all three germ layers. Based on these findings, we examined the expression of stem cell markers in our eGFP population. We found that a majority of eGFP cells were stage-specific embryonic antigen-positive (SSEA-1 ) and that the genetically engineered clones contained more SSEA-1 cells after differentiation than the original D3 mES cells. By negative selection of SSEA-1, we could isolate a neuronal eGFP population of high purity. These results illustrate the complexity of using genetic selection to purify mES cell-derived dopamine neurons and provide a comprehensive analysis of cell selection strategies based on tyrosine hydroxylase expression.' z0 _0 Y( I& @
+ }, S& R8 C* W" wDisclosure of potential conflicts of interest is found at the end of this article. & e7 }" J9 n0 y* T 【关键词】 Genetic engineering Fluorescence-activated cell sorting Parkinson disease Stage-specific embryonic antigen CD- 0 i, c" e2 y+ l9 Q# ] INTRODUCTION+ C$ g7 C2 e h0 N9 n0 Q8 P
/ |) Z+ a W& p2 f/ _) t8 CEmbryonic stem (ES) cells, transplanted either in a naïve or a predifferentiated state, can alleviate symptoms in animal models of Parkinson disease tyrosine hydroxylase (TH) promoters have indicated that primary dopamine neurons can be purified from embryos by FACS and survive replating into culture and transplantation. , C. W. M. C r4 G4 R$ s" W 2 L7 X" K- l* {6 W) ^Transgenic mouse experiments using the rat TH promoter have indicated that 5' sequences 4.5 kilobases (kb) . In our strategy to purify dopamine neurons from mES cells, we compared the ability of a 2.5-kb fragment and a 9-kb fragment of the rat TH promoter to drive eGFP expression in mES cells after in vitro differentiation. Since the integration site could affect the promoter function, we generated multiple mES clones and analyzed their differentiation in vitro by immunofluorescent staining and FACS. One clone was finally selected based on its high overlap in eGFP and TH expression and further characterized in vitro as well as in vivo after FACS and transplantation into naïve mice and 6-hydroxydopamine-lesioned rats.# E% i7 ?5 x% O
1 N: q5 d4 L* u$ K2 X- n
MATERIALS AND METHODS . H6 [7 z; F: D' D2 l 7 _4 F6 f4 o( ^! H* v5 cConstruction of 2.5-kb TH and 9-kb TH Promoter Plasmids 7 {* Y& [5 Y+ V% X4 n5 G/ w3 j5 L7 ?2 Z2 ^+ a0 s
The 2.5- or 9.0-kb promoter region of the rat TH gene (National Center for Biotechnology Information accession no. AF014956>) were inserted into the multiple cloning site of the pEGFP-1 promoterless vector (GenBank accession no. U55761; Clontech, Palo Alto, CA, http://www.clontech.com), upstream of the eGFP gene. The 2.5-kb TH promoter fragment was retrieved by digestion with SfiI, and the 9-kb TH promoter fragment was retrieved by digestion with HindIII. Insert orientation was verified by double diagnostic digestion and sequence analysis of boundaries.: M: F/ ]7 C' g7 b3 m& i8 _! u
+ h, a8 v0 z0 B |; A: h& L# C8 G
mES Cell Propagation 5 t4 K6 O) f1 ^" l+ l" g + ?( n( ?2 s4 l' z- sThe mouse blastocyst-derived embryonic stem cell line D3 (ATCC, Manassas, VA, http://www.atcc.org) was propagated on mitomycin C-treated (10 µg/ml medium; Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.com) primary murine embryonic fibroblasts (PMEFs) (no. 00321; Stem Cell Technologies, Vancouver, BC, Canada, http://www.stemcell.com) in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, http://www.invitrogen.com) supplemented with 2 mM L-glutamine (Invitrogen), 1 mM ¦Â-mercaptoethanol, 1x nonessential amino acids (Invitrogen), 1x nucleosides (Specialty Media; Chemicon, Temecula, CA, http://www.chemicon.com), 15% fetal bovine serum (FBS) (Sigma-Aldrich), 100 U/ml penicillin, 100 µg/ml streptomycin (Invitrogen), and 2,000 U/ml human recombinant leukemia inhibitory factor (R&D Systems Inc., Minneapolis, http://www.rndsystems.com). D3 cells were passaged four times before transfection and were subsequently purified from PMEFs. + G# D- _+ ~7 L+ g8 K 7 y& `8 a" G+ t. vStable Transfection, Clonal Expansion, and Differentiation of mES Cells* G% }) D: T# m" [
$ \& V% v f! r$ ^: F" X0 ?D3 mES cells were transfected with 2.5-kb TH-pEGFP-1, 9-kb TH-pEGFP-1, or pEGFP-1 alone using Lipofectamine plus (Invitrogen). Stably transfected cells were selected in ES medium containing 500 µg/ml neomycin (Clontech). We screened a large number of independent drug-resistant colonies (108 of the smaller-sized colonies of each construct) and aimed to isolate those exhibiting a faithful co-expression pattern of TH and eGFP after in vitro differentiation on PA6 (Riken, Tsukuba, Japan, http//:www.riken.jp) (supplemental online data), to compare which protocol would generate appropriate eGFP neurons for transplantation. Prior to in vitro differentiation, mES cell were purified from STO feeders. Cells used for immunofluorescent staining were fixed in 4% paraformaldehyde for 30 minutes and rinsed with phosphate-buffered saline (PBS). Cells to be used for FACS and transplantation were harvested at days 8¨C11 of differentiation using 0.05% trypsin/EDTA. For both PA6- and MS5-based protocols, the full differentiation time is 14 days. Cells to be further analyzed in vitro after FACS were plated onto primary rat astrocytes (Cambrex, Walkersville, MD, http://www.cambrex.com) and supplemented with 10 ng/ml glial-derived neurotrophic factor (GDNF) and 20 ng/ml brain-derived neurotrophic factor (BDNF).4 g c& n; B1 A+ N
+ Y( a6 p2 U$ K* j% L5 l* iFACS $ P+ } ?- h) G) Z/ ~9 S! m( k: `' `" x& g: _
Cells were differentiated for 8¨C11 days, harvested using 0.05% Trypsin/EDTA (Invitrogen), gently dissociated into a single-cell suspension, and resuspended in phenol-free Hanks' balanced salt solution (Invitrogen) containing 20 mM glucose (Sigma-Aldrich), penicillin-streptomycin, and 2% FBS. Samples were filtered, analyzed, and sorted immediately or were subjected to surface marker staining: mouse anti-stage-specific embryonic antigen-positive (anti-SSEA-1) antibody (0.4 µg/ml; Developmental Studies Hybridoma Bank, Iowa City, IA, http://www.uiowa.edu/dshbwww), incubated for 50 minutes at 4¡ãC, washed, and then incubated with the corresponding secondary antibody followed by washing steps. Cells were analyzed and sorted using a FACSAria cell sorter and FACSDiva software (BD Biosciences, San Diego, http://www.bdbiosciences.com). The population of interest was identified by forward and side scatter gating. Using a 488-nm laser for excitation, GFP positivity was determined according to fluorescence intensity in the GFP channel (490-nm long-pass filters) against autofluorescence in the yellow fluorescent protein (527 LP, 550/30 BP) or red (595 LP, 610/20 BP) channels. D3 mES cells or EV-1 cells, at the same stage of differentiation, were used as the GFP-negative controls. eGFP positivity was confirmed by reanalysis by FACS, and viability was determined by trypan blue exclusion. SSEA-1 positivity was determined according to fluorescence in the red channel compared with negative controls lacking the primary antibody and/or secondary antibodies. Further flow cytometric analysis was performed using FlowJo software (Tree Star, Ashland, OR, http://www.treestar.com). # h5 n: S* Z$ m+ o) }' R * r9 w+ g' a5 c" M6 E5 V6 F0 HAnimal Procedures - p! H; v$ \, r P+ g e5 ~ 0 s4 x0 |+ O/ x5 H$ l% \; G; @All animal procedures were performed in accordance with National Institutes of Health guidelines and were approved by the Animal Institutional Care and Use Committee at McLean Hospital, Harvard Medical School. 2 i" z/ ~( F2 U% h% H4 \ # `* z3 O8 @9 [+ O# K( xTransplantation of eGFP Cells to Naïve Mice and 6-Hydroxydopamine-Lesioned Rats, x! v1 k0 A2 ~+ Z' B3 J. F
! f3 B3 O$ \4 h+ h# aNine-kb TH-eGFP mES cells, FACS purified for eGFP , were resuspended at 100,000 cells per microliter. Female naïve C57/Bl6 mice (n = 15) were grafted with 1¨C2 µl of cell suspension, and Sprague-Dawley rats with unilateral 6-hydroxydopamine lesions (Charles River Laboratories, Wilmington, MA, http://www.criver.com) were grafted with 3 µl of cell suspension (n = 18) or medium alone (n = 7). Transplantations and immunosuppression were performed as previously described (supplemental online data). Mice were sacrificed 4 weeks and rats 10 weeks after transplantation, unless needed earlier. Animals were anesthetized by an i.p. overdose of pentobarbital (150 mg/kg) and perfused intracardially with heparinized saline (0.1% heparin) followed by 4% paraformaldehyde. Brains were removed, postfixed for 6 hours in paraformaldehyde, equilibrated in 20% sucrose, and sectioned on a freezing microtome in 40-µm serially collected coronal slices.+ k( c: O# W. Q9 p+ a# u3 G
" x j- o% W4 OHistological and Stereological Procedures) t9 d% K2 R7 w( m
3 b$ i/ e* T, x+ nFor immunofluorescent staining, cells/sections were incubated with blocking buffer (PBS, 10% normal donkey serum, 0.1% Triton X-100) for 1 hour and subsequently with primary antibodies in blocking buffer overnight. Information on primary antibodies used is given in supplemental online data. The coverslips/sections were subsequently incubated in fluorescent-labeled secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA, http://www.jacksonimmuno.com) in blocking buffer for 1 hour, rinsed in PBS, counterstained with Hoechst 33342 (4 µg/ml), and mounted (Gel/Mount; Biomeda Corp., Foster City, CA, http://www.biomeda.com). For light microscopy, a biotinylated secondary antibody (1:300; Vector Laboratories, Burlingame, CA, http://www.vectorlabs.com) was used, followed by incubation in streptavidin-biotin complex (Vector Laboratories) and 3,3'-diaminobenzidine (Vector Laboratories). Confocal analysis was performed using a Zeiss LSM510/Meta Station (Thornwood, NY, http://www.zeiss.com). Stereology was performed using Stereo Investigator software (MicroBrightField, Williston, VT, http://www.microbrightfield.com) and a Zeiss Axioplan I fluorescent microscope. Graft volumes and TH neuron numbers were calculated using the Cavalieri estimator and Optical fractionator probes. The eGFP/TuJ1 and eGFP/TH overlap in cells after in vitro differentiation (3 coverslips per condition) and the percentage of eGFP or eGFP¨C TH cells in the grafts (n = 6) was determined by random sampling using StereoInvestigator. eGFP and TH overlap in purified eGFP /SSEA-1¨C neurons was assessed by randomized quantification of TH expression (647 nm) in cells identified as eGFP (488 nm) using confocal microscopy (three coverslips were counted). [5 K1 ]$ `( `% o/ \/ h
/ s. G3 M* r# }; W4 G8 ~3 }7 |$ v1 \( \Statistical Analysis, z O- o% F' Y7 f$ [! r1 x
3 F2 N" {( I" k* k6 C
The number of eGFP events in TH-GFP clones versus the original D3 mES clone, as well as the rotations for mES cell-grafted and vehicle-grafted animals, was analyzed using analysis of variance (ANOVA). The extent of overlap between eGFP and TuJ1 or TH after in vitro differentiation of 9-kb TH-eGFP cells was determined by unpaired t test. The percentage of TH cells in the rat grafts that were eGFP or eGFP¨C was analyzed by paired t test. InStat3 software (GraphPad Software, Sa Diego, http://www.graphpad.com) was used for all statistical analyses.* j/ J: g2 L k7 z
( d; E. X8 [9 l6 ?RESULTS * U2 `! [$ Q! ?' w# S$ N, u$ D8 \3 R+ G3 J# n! m
Evaluation of TH-eGFP Promoter Constructs in mES Cells In Vitro - {, J' _+ w% l% l& P . G- D# \! v2 p6 d5 [* SWe transfected naïve D3 mES cells with a 2.5-kb (2.5-kb TH-eGFP) or a 9-kb (9-kb TH-eGFP) rat TH promoter construct driving eGFP expression. G418-resistant clones were screened for overlap between eGFP and TH expression after 14 days of differentiation using the PA6-based protocol ; p : `5 I+ X* h. Z7 w$ L! E7 t) e: X
Figure 1. Evaluation of TH-eGFP promoter constructs in mouse embryonic stem (mES) cells during in vitro differentiation. (A, B): Overlap in eGFP and TH expression in a (A) 2.5-kilobase (kb) TH-GFP clone and in a (B) 9-kb TH-eGFP clone after 14 days of differentiation on PA6. Cultures of 9-kb TH-eGFP clones contained many more eGFP /TH cells compared with the 2.5-kb TH-GFP cultures (yellow co-expression). (C): FACS analysis for eGFP events within an FSC/SSC gate of naïve D3 mES cells autofluorescence), one 2.5-kb TH-eGFP clone (number 91) and three 9-kb TH-eGFP clones (numbers 15, 41, and 93) after 9 days of differentiation on PA6. All 9-kb TH clones showed an expected higher proportion of eGFP events compared with the naïve D3 mES cell line (*, p 4 r6 D; I& J, [' y9 d" r
. I8 Z$ I$ c- C' _" b
Comparison of MS5- and PA6-Based In Vitro Differentiation Protocols: d) a9 C; |2 h7 t; g8 D) H
! X; ~8 @6 ?4 a( |To evaluate which differentiation protocol would better generate appropriate eGFP neurons for transplantation, the 9-kb TH-eGFP clone 15 (9-kb TH-eGFP) was differentiated using the PA6-based (Fig. 2E). Both coculture systems generated few dopamine ¦Â-hydroxylase-positive cells (Fig. 2F), and no eGFP cells had a norepinephric phenotype (Fig. 2F). Based on these findings, we used the MS5-based protocol in all subsequent experiments.0 {- n1 V8 a0 N! L2 f
' H3 E0 g0 Y1 |# F2 O" C1 t! j5 GFigure 2. Comparison of MS5- and PA6-based in vitro differentiation protocols. (A¨CH): The 9-kilobase (kb) TH-eGFP mouse embryonic stem cells were analyzed in vitro after 9 days of differentiation using either the PA6 or MS5-based protocols. (A), enlarged in (B): eGFP and TuJ1 overlap was high using either protocol, although it was significantly higher using the MS5-based protocol (PA6, 94.9% ¡À 0.2% ) (yellow co-expression). Pax2 immunofluorescent staining (E) showed the mid-hindbrain characteristic of the MS5 culture, with very little overlap between eGFP and Pax2, as anticipated based on the different temporal expression of TH and Pax2 during normal development. (F): There were few DBH cells generated in either PA6- or MS5-based protocols, and the DBH staining did not appear to overlap with eGFP expression. Bar graphs depicting overlap between GFP and TuJ1 expression (G) and eGFP and TH expression (H) in cells differentiated using PA6-based (white bars) or MS5-based (black bars) protocol for 9 days (*, p 9 h& x8 L& ], \8 N 5 } n0 W2 c" H9 I6 F; \! \Transplantation and In Vivo Analysis of eGFP-Sorted Cells % s. _' J7 j# K* n1 S , o8 S6 }* B% B+ D' t. n& KIn vitro differentiated 9-kb TH-eGFP cells were FACS sorted for eGFP expression and transplanted. The short-term transplantation to mice showed the presence of eGFP cells and large numbers of TH neurons in all grafts (Fig. 3A¨C3D). Most TH neurons appeared to co-express eGFP (Fig. 3C, 3D). However, some cells expressed only eGFP or only TH (Fig. 3C, 3D). Further analysis of the dopamine phenotype of the eGFP neurons showed that many eGFP cells expressed aromatic L-amino acid decarboxylase (AADC) (Fig. 3E¨C3H), as well as GIRK2 (Fig. 3I¨C3L), which is relatively enriched in A9 compared with other midbrain dopamine neurons (Fig. 3M¨C3O). Unexpectedly, during the long-term transplantation of eGFP cells to 6-hydroxydopamine-lesioned rats, a number of animals started displaying behavioral deficits suggesting teratoma formation and were therefore perfused before the behavioral study was completed. Only animals surviving the entire 10 weeks of testing were included in the behavioral analysis (n = 8). When the number of rotations was analyzed, there was no significant difference between the vehicle and the cell-transplanted groups at any time point (p > .05, ANOVA; supplemental online Fig. 1A). The eight cell-grafted animals that survived until the 10-week time point had a 21% average reduction in the number of rotations (supplemental online Fig. 1B). Graft analysis in four of the surviving animals with reduced number of rotations showed the presence of large numbers of TH neurons: 12,567, 92,945, 102,515, and 165,326, respectively (supplemental online Fig. 1B). These numbers were directly correlated with the size of the grafts (data not shown) but not with the improvement in the number of rotations. The animal with the largest number of TH neurons (Fig. 4A¨C4E) had a 70% decrease in the number of rotations (supplemental online Fig. 1B), and this graft contained some TH neurons, which extended neurites into the host striatum (Fig. 4A, 4C). Approximately 60% of the TH neurons were also eGFP (Fig. 4D, 4E). The grafts also contained cells of neuronal morphology, which were either eGFP /TH¨C or eGFP¨C/TH (Fig. 4D). Further analysis of the dopamine phenotype of the grafted cells showed that most of the eGFP neurons expressed AADC (Fig. 4F¨C4H) and Pitx3 (Fig. 4I¨C4K). All three germ layers, as visualized by cytokeratin (ectoderm), myosin (mesoderm), and villin (endoderm) staining, were present in the grafts (Fig. 4L¨C4N). No colocalization between eGFP and the germ layer markers was identified. 4 v( Y3 s0 r. }7 a1 D: w ( a, N4 n# w E% x" j* q) `3 F. qFigure 3. Short-term transplantation and in vivo analysis of eGFP-sorted cells. (A¨CO): Naïve mice were transplanted with cells sorted for eGFP expression. Grafts were analyzed 4 weeks post-transplantation. (A): Low-power microphotograph of a graft, showing large numbers of TH neurons (the nickel-enhanced 3,3'-diaminobenzidine products appear grayish black; the boxed area is shown enlarged in ). Abbreviations: AADC, aromatic L-amino acid decarboxylase; GFP, green fluorescent protein; GIRK2, G protein-activated inwardly rectifying potassium channel 2; Pitx3, paired-like homeodomain transcription factor 3; TH, tyrosine hydroxylase. * H( u& N; a" p) \3 J" `/ [ p# \) z4 P. L5 w1 U
Figure 4. Long-term xenotransplantation and in vivo analysis of eGFP-sorted cells. (A¨CN): eGFP cell transplants into 6-hydroxydopamine-lesioned rats were analyzed 10 weeks post-transplantation. (A): Low-power microphotograph of a graft, showing large numbers of TH neurons (the nickel-enhanced DAB products appear grayish black; the boxed area to the left is shown enlarged in ). The two groups were not significantly different (p > .05, paired t test) due to the high variability in overlap between TH and eGFP between different grafts. Many of the eGFP neurons displayed characteristics of midbrain dopamine neurons, as shown by the overlapping expression with AADC (F¨CH) and Pitx3 (I¨CK). Grafts contained all three germ layers, as visualized by staining for cytokeratin (L), myosin (M), and villin (N), but no overlapping expression with eGFP was detected. Scale bars = 200 µm (A), 50 µm (B, C, F¨CN), and 25 µm (D). Abbreviations: AADC, aromatic L-amino acid decarboxylase; eGFP, enhanced green fluorescent protein; GFP, green fluorescent protein; Pitx3, paired-like homeodomain transcription factor 3; TH, tyrosine hydroxylase., L$ Y! T- Y1 M! ?1 E
) M" {7 R+ \. _/ I1 `3 v0 d+ G
Identification of Proliferative eGFP Cells in the Grafts& a7 ?+ c# j, b% i% t0 I" j
1 ^* `( p' Z0 A" W: |; z
Further analysis showed that in addition to eGFP cells of a neuronal phenotype, grafts contained clusters of immature eGFP /SSEA-1 cells (Fig. 5A¨C5I). All grafts analyzed contained proliferative cells, as demonstrated by Ki67 staining (Fig. 5E¨C5I). The majority of Ki67 cells in the grafts were not eGFP . However, a large proportion of the eGFP cells showing a non-neuronal morphology were Ki67 and some of these eGFP /Ki67 cells also expressed SSEA-1 on their surface (Fig. 5E¨C5I). There were large nestin areas in the grafts surrounding the GFP cells of immature morphology, but very few, if any, cells were GFP /nestin (Fig. 5J¨C5L).# e M. g5 d7 c* D; w7 u. D7 D8 u& j1 s
4 r7 q2 v9 t4 l3 T
Figure 5. Identification of proliferative eGFP cells in the grafts. (A¨CL): Analysis of mouse grafts 4 weeks post-transplantation showed that there were cluster of SSEA-1 /eGFP cells in some grafts (). Abbreviations: GFP, green fluorescent protein; SSEA, stage-specific embryonic antigen. E: }+ w( g5 X) d. Q% g9 v) E. I0 n6 s
Purification of Neurons from In Vitro Differentiated TH-eGFP Cells by Negative Selection for SSEA-1( j7 a# u: U O7 {8 x( e
- S9 n$ Z- e6 F6 } [9 o2 T- a
Immunofluorescent analysis of differentiated TH-eGFP mES cells showed that there were SSEA-1 cells present in the cultures. Most individual colonies consisted of many eGFP cells of neuronal morphology with few or no SSEA-1 cells. In such colonies, few or no cells were eGFP /SSEA-1 (Fig. 6A¨C6D). Some colonies, however, contained a majority of SSEA-1 cells (Fig. 6B, 6E, 6F), and in some instances, these cells were eGFP (Figs 6E, 6F). These eGFP /SSEA-1 cells had a non-neuronal morphology and a lower expression of eGFP than the eGFP cells with neuronal morphology (Fig. 6E, 6F). Some of these eGFP /SSEA-1 cells also stained for Oct-4 (supplemental online Fig. 2). The expression of SSEA-1 was not correlated with the size of the colony, since adjacent colonies of the same size were sometimes entirely SSEA-1 or contained only eGFP cells of neuronal morphology (Fig. 6B). Dissociation and replating of the TH-eGFP cultures after 9 days of differentiation, as if the cells were to be processed for FACS, surprisingly showed that most cells surviving this procedure were SSEA-1 cells of a non-neuronal morphology (Fig. 6G). This experiment also showed that some SSEA-1 cells expressed eGFP at a high intensity after dissociation (Fig. 6G). Live staining and FACS of differentiated TH-eGFP cells for SSEA-1 showed that the original D3 mES cell clone (n = 3) used for the genetic manipulations contained fewer SSEA-1 events (cells) after differentiation, compared with both the empty vector (EV-1) (n = 3) and 9-kb TH-eGFP clone (n = 3) that were derived from this mES cell line (Fig. 6H). Karyotypic analysis did not reveal any acquired chromosomal abnormalities in our 9-kb TH-eGFP clone compared with the D3 mES cells (supplemental online Fig. 3), which could have explained the increase in SSEA-1 events. To remove cells with proliferative capacity and acquire eGFP neurons only from differentiated TH-eGFP cells, we FACS sorted eGFP /SSEA-1¨C cells. A very small fraction of cells that were present after the trypsin dissociation and the FACS procedure were eGFP /SSEA-1¨C (Fig. 7A). The majority of cells sorted for eGFP alone were SSEA1 and had a non-neuronal morphology (Fig. 7B). However, a double sort for the fraction of cells that were eGFP /SSEA-1¨C (1.4% of the parental population, n = 6) resulted in a population of cells with mostly neuronal morphology (Fig. 7C, 7D). Approximately 60% of these eGFP neurons stained for TH (Fig. 7D).: H: \, m& S- p) \; H
0 E: k/ Y0 U X& x9 X
Figure 6. In vitro analysis of SSEA-1 expression in differentiated mouse embryonic stem (mES) cell cultures. (A¨CH): Analysis of in vitro-differentiated 9-kilobase (kb) TH-eGFP cells showed that most colonies contained many eGFP neurons and few SSEA-1 cells and no or very few cells that were eGFP /SSEA-1 (), and in some instances, these cells were SSEA-1 /eGFP (E, F). The eGFP /SSEA-1 cells appeared to have a lower expression of eGFP than the eGFP cells with neuronal morphology before dissociation (C, F). The expression of SSEA-1 did not appear to be correlated with the size of the colony (B). Dissociation of cultures followed by replating showed that most cell surviving this procedure were SSEA-1 (G). Fluorescence-activated cell sorting analysis showed that 9-kb TH-eGFP cells, as well as the EV1-transfected mES cells, contained a higher number of SSEA-1 cells than the original D3 mES cells used for the genetic manipulations (H). Scale bars = 100 µm (A¨CC, E) and 50 µm (D, F, G). Abbreviations: k, kilobase; EV1, empty vector; GFP, green fluorescent protein; SSEA, stage-specific embryonic antigen; TH, tyrosine hydroxylase. ' J5 e( G- @, w) b4 P: q$ H 1 A: l) l% I; M8 fFigure 7. Purification of neurons from in vitro-differentiated TH-eGFP cultures by negative selection for SSEA-1. Live stain and fluorescence-activated cell sorting (FACS) for eGFP and SSEA-1, after in vitro differentiation on MS5 for 9 days, showed that most eGFP cells were SSEA1 , although a small population of cells that were eGFP /SSEA-1¨C could be isolated (A). The EV-1-transfected mouse embryonic stem cell clone, differentiated for the same length of time as the 9-kb TH-eGFP clone, was used as a negative control for fluorescence (A). Plating of cells sorted only for eGFP fluorescence resulted in a population consisting mainly of SSEA-1 cells of a non-neuronal morphology (2 days in vitro post-FACS) (B). Cells negatively sorted for SSEA-1 and positively for eGFP gave a population of high neuronal purity (A, C, D). Some of the eGFP neurons from this double sort also expressed TH (2 days in vitro post-FACS) (D). Abbreviations: Ab, antibody; eGFP, enhanced green fluorescent protein; EV-1, empty vector; GFP, green fluorescent protein; kb, kilobase; SSEA, stage-specific embryonic antigen; TH, tyrosine hydroxylase. / e/ S# d5 x7 B( r1 o) o: F7 k: f3 _- f9 d
DISCUSSION$ i' `, j* W6 d& C/ F: H, w. g% L
' @$ {2 q5 s4 J$ z$ }9 }- t: Y% ]3 TGenetic engineering of mES cells using transcription factors such as Nurr1 , which could partly explain the presence of eGFP /TH¨C neurons of a dopamine cell morphology. Once the promoter region is without activation, TH expression will fade away faster than the eGFP expression. * ^$ z0 a7 I& L' A4 Q9 r6 G( b( I, O& o, D6 t& @7 \& k9 X
Transplantation of 9-kb TH-eGFP-sorted cells generated grafts with large numbers of TH neurons with an appropriate midbrain phenotype. However, our grafts contained up to 135-fold more TH neurons than expected, based on previous analyses of FACS-sorted primary embryonic TH neurons . This shows that even neurons that have extended long processes in vivo and/or in vitro can survive dissociation./ N( z7 l, n6 a. I" ^8 G3 s! S0 Q; U
, k7 U$ P9 k# {$ CDespite the large number of TH neurons in the grafts, some of which extended fibers into the host, there was no general significant behavioral improvement. There were TH neurons in the grafts that extended neurites into the host, although most TH neurons did not. Improvement in amphetamine-induced rotational behavior can, however, be seen without morphological integration of grafted cells . The reason we do not see improvement is likely due to the size and disruptive nature of the grafts. The lack of correlation between the total number of TH neurons in the grafts and improvement in the number of amphetamine-induced rotations supports this hypothesis. In addition, the presence of other cell types in the grafts makes it very difficult to interpret the behavior. " d. d+ G. K* O% h, K ( ]/ Y& D- c ~7 i0 feGFP cells to be used for transplantation were sorted using a high purity mask to avoid the inclusion of eGFP¨C cells in our positive fraction. Reanalysis of sorted cells did, however, reveal the presence of GFP¨C cells in the eGFP sorted fraction (90% of purified cells expressed eGFP; data not shown), perhaps partly due to bleaching or cell damage. The extent of eGFP¨C cells in the eGFP fraction was similar to a previous study where teratoma formation after transplantation of 200,000 cells was avoided . ES cell cultures are never completely synchronized, and cells of many developmental stages are therefore present simultaneously. Although the integration site of our construct could influence the expression of eGFP, the transient expression of TH in multiple cell types during development could also explain the presence of eGFP cell with proliferative potential. Any approach using TH to label dopamine neurons from ES cells, whether different lengths of the promoter are used or a knock-in strategy, will generate a mixed population of cells unless the ES culture systems can be completely synchronized in time and designed to specifically generate only one cell type. 0 `5 f. g1 b: t; D7 Y. @' }3 }- G( a! ~2 `. |9 L3 Q$ L. T
Normal transient expression of TH during development could result in the generation of eGFP cells of multiple cell lineages, as previously discussed. However, the expression of eGFP in a context of SSEA-1 in our cells could be due to misexpression related to transformation of the mES cells during clonal expansion. SSEA-1, a cell surface carbohydrate antigen (CD15 or Lewisx antigen), is typically expressed in preimplantation mouse embryos beginning at the eight-cell stage, in teratocarcinoma stem cells, ES cells, and adult CNS stem cells, but not in their differentiated derivatives . In that study, no further characterization of these eGFP /TH¨C cells was reported, but it seems possible that some of these cells could have been SSEA-1 . In our study, we further purified the population of GFP /SSEA-1¨C cells by FACS. This population had high neuronal purity and contained many cells with co-expression of eGFP and TH. The efficiency of FACS for these neuronal eGFP cells (SSEA-1¨C) was, however, too low to enable a meaningful transplantation study for in vivo analysis. 3 d% C9 G) J5 A# k1 i: N" A 6 s, i; b0 `6 D7 QIn conclusion, our study illustrates the complexity of using a single marker for selection of a specific cell population in ES cell cultures, which are not synchronized in time or specific enough to generate only one cell type. Positive selection for eGFP combined with a negative selection of an immature marker could provide an enriched neuronal population for transplantation in our context. Similar combinatorial strategies might be necessary also when other cellular markers for selection of a mature specific cell type are used.) Q) {5 c& t9 Y) J* d B
0 ]. z* G: r* t8 ~1 ADISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST * V3 Z: w `! k4 ]5 ^+ Q" R& Y8 q2 J! j8 S
The authors indicate no potential conflicts of interest. c) f' V5 V4 v& { / S$ I) K/ `1 M5 ^- o: I; e) L$ oAcknowledgments$ C2 ]( \% o1 W. N+ X
5 ^( E; \% J- x6 A5 s( w" f- H7 AThis work was supported by Udall Parkinson's Disease Center of Excellence grant P50 NS39793 and the Orchard, Anti-Aging, and Stern foundations. E.H. was supported by a fellowship from the Swedish Brain Foundation. % {2 R' b% _. L6 m$ P 【参考文献】 5 m; R/ e: E9 W" n: o1 w % U2 F4 j6 ~; y; }6 y- }9 c3 c
3 q% w# |9 g/ D2 i- G, {+ b5 SBjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002;99:2344¨C2349.+ M5 M+ ~. S; b% `
* v F$ U& H' T! a$ m& T. V6 k5 v
Kim JH, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418:50¨C56. 1 _7 Z7 U+ O9 S; T' p( |5 N- K7 G* ]- w( U/ D* u& {
Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 2003;21:1200¨C1207. ) P7 Y) l: ^. a$ m! {% b/ Q4 l+ y* j6 D% U+ ^4 I+ L, e
Ben-Hur T, Idelson M, Khaner H et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. STEM CELLS 2004;22:1246¨C1255. 4 m1 i T' x* H+ q$ A$ ?% I/ }7 X9 l* ]' u! y7 R, O
Arnhold S, Klein H, Semkova I et al. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 2004;45:4251¨C4255. Y- ~1 h8 w0 r& h7 h0 l8 p
( l7 n. H6 y" QThinyane K, Baier PC, Schindehutte J et al. Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: Histological characterization of the grafted cells. Brain Res 2005;1045:80¨C87.0 D6 ?! w" p7 F. D2 `% H
0 h% X+ T, J& P TFukuda H, Takahashi J, Watanabe K et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. STEM CELLS 2006;24:763¨C771.& @2 M" K& m/ K9 f* h" V
2 N2 [# G) Y5 L* P$ i1 s' E3 hChung S, Shin BS, Hedlund E et al. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 2006;97:1467¨C1480.0 ^, a4 o# F9 p
! o% U: J. J3 M7 O6 v8 X5 T- R
di Porzio U, Rougon G, Novotny EA et al. Dopaminergic neurons from embryonic mouse mesencephalon are enriched in culture through immunoreaction with monoclonal antibody to neural specific protein 4 and flow cytometry. Proc Natl Acad Sci U S A 1987;84:7334¨C7338. 3 y9 F4 G. o& b+ s , D3 ]: [1 w+ Z& GKerr CW, Lee LJ, Romero AA et al. Purification of dopamine neurons by flow cytometry. Brain Res 1994;665:300¨C306. ; U3 Y, a' R- f# D! S$ p' u2 ~* a. P/ F" w+ a. r+ ~8 q/ k. _
Sawamoto K, Nakao N, Kobayashi K et al. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc Natl Acad Sci U S A 2001;98:6423¨C6428.9 z1 K" y! q- ~; j
. f/ M$ x& P1 |7 B5 k2 u* ?$ nDonaldson AE, Marshall CE, Yang M et al. Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture. Mol Cell Neurosci 2005;30:108¨C117.: [3 H" o- D' p* m
$ ^( A: l) [: L; @+ TSchimmel JJ, Crews L, Roffler-Tarlov S et al. 4.5 kb of the rat tyrosine hydroxylase 5' flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors. Brain Res Mol Brain Res 1999;74:1¨C14. 3 k+ p( i# l8 z5 h2 Q5 S- K* q, `% E* i; _3 @: G
Banerjee SA, Hoppe P, Brilliant M et al. 5' flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice. J Neurosci 1992;12:4460¨C4467. " i; O/ T6 t0 B% Z7 \; p+ k2 Z2 z: r( Z) v. g U, @; N1 B
Trocm¨¦ C, Sarkis C, Hermel JM et al. CRE and TRE sequences of the rat tyrosine hydroxylase promoter are required for TH basal expression in adult mice but not in the embryo. Eur J Neurosci 1998;10:508¨C521. ( g; { V% v; L5 r" K0 ~1 X7 n$ P
Liu J, Merlie JP, Todd RD et al. Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis. Brain Res Mol Brain Res 1997;50:33¨C42. . [$ |0 s E$ H( @: n2 r6 r. x: ]9 ]: j* m: ^4 ?( O$ _
Min N, Joh TH, Kim KS et al. 5' upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice. Brain Res Mol Brain Res 1994;27:281¨C289.) a4 {5 ~7 B- K7 z9 o& @
# x/ @! \, ~5 R' SKim SJ, Lee JW, Chun HS et al. Monitoring catecholamine differentiation in the embryonic brain and peripheral neurons using E.coli lacZ as a reporter gene. Mol Cells 1997;7:394¨C398.' g% d! Y0 z& R" A2 A8 N
6 ]3 p! D3 D5 X; b' A2 CKessler MA, Yang M, Gollomp KL et al. The human tyrosine hydroxylase gene promoter. Brain Res Mol Brain Res 2003;112:8¨C23.5 F X! }7 c/ i. o2 w0 ~# Q
' S( g6 {6 L; Z, A' [2 w
Nagatsu I, Karasawa N, Yamada K et al. Expression of human tyrosine hydroxylase-chloramphenicol acetyltransferase (CAT) fusion gene in the brains of transgenic mice as examined by CAT immunocytochemistry. J Neural Transm Gen Sect 1994;96:85¨C104. Y' P! H* H& |6 O7 ~7 [4 R+ H4 O9 V' A3 a# e: v1 G& w3 u( B
Sasaoka T, Kobayashi K, Nagatsu I et al. Analysis of the human tyrosine hydroxylase promoter-chloramphenicol acetyltransferase chimeric gene expression in transgenic mice. Brain Res Mol Brain Res 1992;16:274¨C286. 7 X& s6 I: I: k" J. m1 t* M" J. H, t
Morgan WW, Walter CA, Windle JJ et al. 3.6 kb of the 5' flanking DNA activates the mouse tyrosine hydroxylase gene promoter without catecholaminergic-specific expression. J Neurochem 1996;66:20¨C25.3 A, W- ~3 J1 J: ]6 ~
1 k$ U" j) I6 p4 v2 [1 @$ ?Kim KS, Lee MK, Carroll J et al. Both the basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cAMP response element. J Biol Chem 1993;268:15689¨C15695. * Y1 E/ o: a# }* K1 x; N7 ^" x* k* t4 l
Kawasaki H, Mizuseki K, Nishikawa S et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000;28:31¨C40. 2 m6 B1 P8 Z; D! C7 R8 |& d; @6 F/ n+ F# v
Ye W, Shimamura K, Rubenstein JL et al. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998;93:755¨C766.: V( r$ } [1 Q
. s; t3 x/ w) }; a2 q; {Hidalgo-S¨¢nchez M, Millet S, Simeone A et al. Comparative analysis of Otx2, Gbx2, Pax2, Fgf8 and Wnt1 gene expressions during the formation of the chick midbrain/hindbrain domain. Mech Dev 1999;81:175¨C178.2 e' _8 e, q! O2 w4 L. O$ r
# Z! U0 _4 Y- F) e8 ?8 Y0 nYe W, Bouchard M, Stone D et al. Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. Nat Neurosci 2001;4:1175¨C1181. , Q! y, g- o v: b2 @5 N9 ^( r: f, G. K( z' i! n* @
Schein JC, Hunter DD, Roffler-Tarlov S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev Biol 1998;204:432¨C450.+ y+ g, ~2 C# L3 R/ p% Y
& ^8 d5 b' n2 R3 w: [+ s( j4 L- jInanobe A, Yoshimoto Y, Horio Y et al. Characterization of G-protein-gated K channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J Neurosci 1999;19:1006¨C1017. ' i- q5 k; D2 } 0 v" b* O$ o% y& IChung CY, Seo H, Sonntag KC et al. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet 2005;14:1709¨C1725. % a, X: H4 m# I f6 u$ v5 z% g" a- S; o. y3 j
Semina EV, Reiter RS, Murray JC. Isolation of a new homeobox gene belonging to the Pitx/Rieg family: Expression during lens development and mapping to the aphakia region on mouse chromosome 19. Hum Mol Genet 1997;6:2109¨C2116.7 Y. h: D- l& `' h6 v. D# n
6 b$ x) y( u+ X* X. L" s v7 [Smidt MP, van Schaick HS, Lanctot C et al. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci U S A 1997;94:13305¨C13310. $ R/ n i, n3 g# ^5 k7 J% T5 _7 Y5 b Y+ |0 z
Chung S, Sonntag KC, Andersson T et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 2002;16:1829¨C1838.) V+ n* F* e/ Q6 m7 k, m, t- a X
; M/ a2 t J: _" f0 ~! JAndersson E, Tryggvason U, Deng Q et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006;124:393¨C405. ; B8 y* f: _5 q! l8 P) V* _8 n8 l% u& X% M# B
Chung S, Hedlund E, Hwang M et al. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Mol Cell Neurosci 2005;28:241¨C252.4 E3 C. ]2 {4 m9 {9 h0 b9 T
7 U7 l N7 v8 ^2 J: P: C
Sonntag KC, Pruszak J, Yoshizaki T et al. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. STEM CELLS 2007;25:411¨C418. , P1 R3 w" G" ?% D/ m; W, ^/ ^9 p( T- H5 v2 E- `
Roy NS, Cleren C, Singh SK et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006;12:1259¨C1268.8 V; e6 L) U' x- U' w
0 W4 F6 K* Q3 b8 Q/ C2 R
Matsushita N, Okada H, Yasoshima Y et al. Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development. J Neurochem 2002;82:295¨C304." r& B9 O0 u! p; d; g/ N8 }* N- m
' E# `- z1 p2 I" ^) V# |Gelman DM, Noain D, Avale ME et al. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons. Genesis 2003;36:196¨C202.7 Y6 z* J% L0 I8 e. u$ ?
. L5 Y6 u( M9 j G
Meloni R, Albanese V, Ravassard P et al. A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 1998;7:423¨C428. 0 K! I( @& t* W8 z, K0 }/ T / a, M% }( N. rAlban¨¨se V, Biguet NF, Kiefer H et al. Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 2001;10:1785¨C1792. # Z6 D3 L- d' e. c) P# S! G- q$ T& B! x \2 c# J. L
Lenartowski R, Goc A. Tissue-specific association of the human tyrosine hydroxylase gene with the nuclear matrix. Neurosci Lett 2002;330:151¨C154.- S" |& _! w3 p: c
8 X+ c3 g/ [0 p, ]1 i- |
Kelly BB, Hedlund E, Kim C et al. A tyrosine hydroxylase-yellow fluorescent protein knock-in reporter system labeling dopaminergic neurons reveals potential regulatory role for the first intron of the rodent tyrosine hydroxylase gene. Neuroscience 2006;142:343¨C354. 3 E) ?% E" m9 m* ^2 Z3 C3 [. w# y0 G- E; e
Paulding WR, Czyzyk-Krzeska MF. Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3'-untranslated region. J Biol Chem 1999;274:2532¨C2538. 1 m( i Z6 t( T/ \. ?7 q& O: h 8 A# x* q! M" H2 j) KWu DK, Cepko CL. The stability of endogenous tyrosine hydroxylase protein in PC-12 cells differs from that expressed in mouse fibroblasts by gene transfer. J Neurochem 1994;62:863¨C872.( v/ B1 w5 O* j$ K4 y* z _
: ~. Q6 B) c' ZArlotta P, Molyneaux BJ, Chen J et al. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 2005;45:207¨C221. 6 g9 ]1 {( G4 |2 Q7 p. t# _- Z, n) ~) h5 |# O( y- f6 P! ? z
Ozdinler PH, Macklis JD. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 2006;9:1371¨C1381. 5 |5 r7 s6 x$ ?% F& s% V' I- \3 o* `6 u5 ~1 K' |
Lobo MK, Karsten SL, Gray M et al. FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat Neurosci 2006;9:443¨C452. / J2 @. E7 g7 ]2 g: f ! c) P: Q/ z# H1 R, l# H4 \Timmer M, Grosskreutz J, Schlesinger F et al. Dopaminergic properties and function after grafting of attached neural precursor cultures. Neurobiol Dis 2006;21:587¨C606. . T3 Z# O4 _) Q( v" ?: U a0 u( [0 B- t- `% x; E! }Baier PC, Schindehutte J, Thinyane K et al. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration. STEM CELLS 2004;22:396¨C404. & I6 \$ a9 y2 T 0 x7 j, U5 ]. n4 r: E2 pLindeberg J, Usoskin D, Bengtsson H et al. Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus. Genesis 2004;40:67¨C73.1 C( f% J0 U, I6 z. |9 \; ?
3 @) r+ l% Y3 q. K' ~0 N/ p
Jonakait GM, Markey KA, Goldstein M et al. Transient expression of selected catecholaminergic traits in cranial sensory and dorsal root ganglia of the embryonic rat. Dev Biol 1984;101:51¨C60. 4 b3 h8 ^' ^( E# ~5 D b0 u! _! b Z/ P" h
Foster GA, Schultzberg M, Dahl D et al. Ephemeral existence of a single catecholamine synthetic enzyme in the olfactory placode and the spinal cord of the embryonic rat. Int J Dev Neurosci 1985;3:597¨C608. + ?0 G/ g* ^) C6 O+ M3 _7 b" i8 J6 }; B$ Y
Wulle I, Schnitzer J. Distribution and morphology of tyrosine hydroxylase-immunoreactive neurons in the developing mouse retina. Brain Res Dev Brain Res 1989;48:59¨C72.- p# _' A0 @* | \- f0 z( \4 D
8 U, _+ Q% s" E1 P- QVersaux-Botteri C, Verney C, Zecevic N et al. Early appearance of tyrosine hydroxylase immunoreactivity in the retina of human embryos. Brain Res Dev Brain Res 1992;69:283¨C287. . H1 z& H8 X9 j3 r" d' a& A + `/ a$ ^6 P0 h) S( ]7 xTeitelman G, Gershon MD, Rothman TP et al. Proliferation and distribution of cells that transiently express a catecholaminergic phenotype during development in mice and rats. Dev Biol 1981;86:348¨C355. & ~- @+ [! R$ f3 @3 w0 R+ | T) U( f- R
Baetge G, Gershon MD. Transient catecholaminergic (TC) cells in the vagus nerves and bowel of fetal mice: Relationship to the development of enteric neurons. Dev Biol 1989;132:189¨C211. & j5 u- d) K' u9 G* \ - ]. ^1 \$ r8 j- h+ I2 s% V% sBaetge G, Pintar JE, Gershon MD. Transiently catecholaminergic (TC) cells in the bowel of the fetal rat: Precursors of noncatecholaminergic enteric neurons. Dev Biol 1990;141:353¨C380.* I+ F6 S$ @3 G, N& M3 a* l0 z) S
: L2 W/ x3 w1 K) U7 Z C: k" m2 L; oTeitelman G, Joh TH, Reis DJ. Transformation of catecholaminergic precursors into glucagon (A) cells in mouse embryonic pancreas. Proc Natl Acad Sci U S A 1981;78:5225¨C5229.) s2 |% V5 r3 I3 j- R
4 x& a3 A, ~* k3 e% PSatoh J, Suzuki K. Tyrosine hydroxylase-immunoreactive neurons in the mouse cerebral cortex during the postnatal period. Brain Res Dev Brain Res 1990;53:1¨C5.+ @& _. a; T; d
8 g7 g4 e$ K$ }" nKomori K, Sakai M, Karasawa N et al. Evidence of transient expression of tyrosine hydroxylase immunoreactivity in the mouse striatum and the effects of colchicine. Acta Histochem Cytochem 1991;24:223¨C231.3 O& c/ g; R+ }5 ?% L: ~2 B& ^/ h ?
4 k7 b5 _5 w* ^, UJaeger CB, Joh TH. Transient expression of tyrosine hydroxylase in some neurons of the developing inferior colliculus of the rat. Brain Res 1983;313:128¨C132. % K E6 ?2 F+ M0 }# O0 S+ j / T6 V" o' M U4 @+ l7 ^Rothman TP, Specht LA, Gershon MD et al. Catecholamine biosynthetic enzymes are expressed in replicating cells of the peripheral but not the central nervous system. Proc Natl Acad Sci U S A 1980;77:6221¨C6225. l* S7 N1 E5 n0 T* v, L G3 L# R& q6 Y5 t: Q) E
Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A 1978;75:5565¨C5569.4 K/ q- f9 m' w& t, ?
0 Y! n& l4 L2 M( h5 _
Knowles BB, Pan S, Solter D et al. Expression of H-2, laminin and SV40 T and TASA on differentiation of transformed murine teratocarcinoma cells. Nature 1980;288:615¨C618. ! q, ?1 c: V$ a8 f0 `3 i ) j1 M7 v, W* ~- `8 b8 i- fFox N, Damjanov I, Martinez-Hernandez A et al. Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. Dev Biol 1981;83:391¨C398. 8 U; A0 p; d1 m/ i* [ - l) d' c: y" l) C8 KEggens I, Fenderson B, Toyokuni T et al. Specific interaction between Lex and Lex determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem 1989;264:9476¨C9484. 2 i' q4 F4 z' D% j9 o# i2 i. |0 V
Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 2002;35:865¨C875.( K+ a2 `$ m1 G `! z
$ ]: |) b* z) O, c4 ?. G8 s% K1 gLiu X, Wu H, Loring J et al. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn 1997;209:85¨C91.1 F+ b( Z7 r! }
1 p' j# Y, L) a( c( j8 f$ O) y. USugawara A, Goto K, Sotomaru Y et al. Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp Med 2006;56:31¨C34.- w: c1 c# u. h
) P! I, u5 u M- d |; lYoshizaki T, Inaji M, Kouike H et al. Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett 2004;363:33¨C37.作者: tuanzi 时间: 2015-6-16 15:27